Transcatheter Mitral Valve Market is expected to reach a valuation of US$ 3.3 Bn by the end of 2032- Future Market Insights, Inc.

News provided by

Jul 11, 2022, 11:37 ET

Approvals of Tricuspid Regurgitation Products to Push Transcatheter Mitral Valve Market to 13.5% CAGR by 2032. The German market share is likely to remain at the forefront in Europe for transcatheter mitral valve sales

NEWARK, Del., July 11, 2022 /PRNewswire/ -- As per the latest industry analysis by Future Market Insights, valuation of the global transcatheter mitral valve market was around US$ 831.1 Mn in 2021 and is projected to exhibit a CAGR of 13.5% over the forecast period. The market is expected to reach US$ 3.3 Bn in 2032.

Following the success and widespread use of transcatheter aortic valve replacement (TAVR), physician-investigators have turned their attention to percutaneous replacement of a diseased mitral valve (MV).

However, while transcatheter aortic valve replacement (TAVR) has already established itself as the gold standard for treatment of aortic stenosis (AS) in patients who are at high risk for conventional surgery, transcatheter mitral valve replacement (TMVR) is yet to reach the same level.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15165

MV disease is more frequent than AS, and surgical treatment for degenerative mitral regurgitation is still considered to be the gold standard. TMVR may evolve as a promising treatment alternative for patients with high surgical risk who are denied surgery and for whom medical therapy is insufficient.

Transcatheter mitral valve repair is a rapidly developing field that has the potential to be embraced as a viable alternative to surgery among certain patients. The targeted section of MV apparatus helps to recognize TMVR devices.

Need to transform a transapical treatment to a fully transcatheter (transfemoral and transeptal) procedure is set to surge in the upcoming decade on the back of rising number of preclinical programs under development.

Transcatheter therapies will need to follow stringent indications due to strict patient selection criteria for each device or use multiple procedures in a single repair process for severe MV disease to attain outcomes comparable to open surgery in degenerative mitral regurgitation.

Owing to the above-mentioned factors, the global transcatheter mitral valve market is set to gain traction among industry players.

Key Takeaways: Transcatheter Mitral Valve Market

By product, the transcatheter mitral valve repair segment held approximately 85.4% of share in 2021 and is anticipated to lead in 2022-2032.
Based on indication, the mitral regurgitation segment generated a transcatheter mitral valve market share of around 83.1% in 2021.
By end user, the hospitals segment is expected to dominate the transcatheter mitral valve market with a projected CAGR of 13.6% during the forecast period.
North America transcatheter mitral valve market generated a share of around 55.9% in 2021.
Germany held a market share of about 9.2% in 2021 and is likely to remain at the forefront in the Europe transcatheter mitral valve market.

For critical insights, request for PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15165

"Development of unique transcatheter mitral valve products and growing advancements in the field of degenerative mitral regurgitation are expected to push the global transcatheter mitral valve market in the forecast period," says an analyst of Future Market Insights.

Competitive Landscape: Transcatheter Mitral Valve Market

The transcatheter mitral valve market is consolidated with the presence of various established players across the globe. Key players are enforcing clinical evaluations of pipelined products to strengthen their market positions. They are also investing huge sums in research and development activities to generate more revenues in the global market.

In March 2022, Edwards Lifesciences received approval from the U.S. Food and Drug Administration (FDA) for its MITRIS RESILIA valve. It is a tissue valve replacement which is specifically designed for the heart's mitral position.
In April 2020, Abbott received the CE Mark approval for its Tendyne Transcatheter Mitral Valve Implantation System and TriClip Transcatheter Tricuspid Valve Repair System under its structural heart device portfolio.

More Valuable Insights on Transcatheter Mitral Valve Market

Future Market Insights offers a unique perspective and actionable insights on the transcatheter mitral valve market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on product (transcatheter mitral valve replacement and transcatheter mitral valve repair), indication (mitral stenosis and mitral regurgitation), and end user (hospitals, ambulatory surgical centers, and cardiac catheterization laboratories) across seven key regions of the world.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-15165

Transcatheter Mitral Valve Market Outlook by Category

By Product:

Transcatheter Mitral Valve Replacement
Transcatheter Mitral Valve Repair

By Indication:

Mitral Stenosis
Mitral Regurgitation

By End User:

Hospitals
Ambulatory Surgical Centers
Cardiac Catheterization Laboratories

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business.

Buy Now@ https://www.futuremarketinsights.com/checkout/15165

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply-Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption/Usage Analysis

4.2. Pipeline Assessment

4.3. Regulatory Landscape

4.4. Reimbursement Outlook

4.5. Key Marketing & Promotional Strategies Adopted By Companies

4.6. PESTLE Analysis

4.7. Porter's Analysis

Get detailed TOC @ https://www.futuremarketinsights.com/toc/rep-gb-15165

Have a Look at Related Research Reports of Healthcare

Transcatheter Heart Valve Replacement (TAVI) Market Size : The transcatheter heart valve replacement market is predicted to advance at an impressive CAGR of 12% from 2022 to 2032.

Prosthetic Heart Valve Market Share : The prosthetic heart valve market is likely to secure a CAGR of 11% through 2032 and market size is estimated to cross US$ 23.16 Bn by 2032.

Transcatheter Bioprosthesis Market Trends : Transcatheter bioprosthesis is rapidly growing in the lower risk population and the midterm durability of transcatheter bioprosthesis is further expected to encourage the growth of the global transcatheter bioprosthesis market.

Home Sleep Apnea Testing Market Outlook : The home sleep apnea testing market is likely to register a CAGR of 14.4% during the forecast period, and is anticipated to reach a market share of US$ 3.09 Bn in 2032

Biomaterials Market Technology : The global biomaterials market is expected to reach a market valuation of US$ 156.2 Billion by the year 2022, accelerating with a moderate CAGR of 15.4% by 2022-2032.

Implantable Collamer Lens Market Forecast : The global implantable collamer lens market is expected to reach a valuation of US$ 244.8 Mn in 2022. Demand is projected to increase at a CAGR of 13.1% over the forecast period, with the market size reaching US$ 838.2 Mn by 2032

Canine Flu Therapeutics Market Growth : Global canine flu therapeutics market demand is anticipated to be valued at US$ 1975.4 Million in 2022, forecast to grow at a CAGR of 4.1% to be valued at US$ 3067.8 Million from 2022 to 2032.

Pipette Tips Market Analysis : The pipette tips market is predicted to grow at 8.0% CAGR through 2032 & market size is anticipated to be over USD 680.40 Million in 2022.

Cell Culture Sampling Devices Market Demand : The global cell culture sampling devices market garnered a market value of US$ 2,584.9 Million in 2022

Cervical Dysplasia Treatment Market Type : Expanding at a CAGR of 7.9%, the global Dental Imaging Equipment Market is projected to increase from a valuation of US$ 2.99 Bn in 2021 to US$ 5.91 Bn by 2030

About Us  

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years. 

Contact:

Future Market Insights Inc.  
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA  
T: +1-845-579-5705  
Report: https://www.futuremarketinsights.com/reports/transcatheter-mitral-valve-market
For Sales Enquiries: [email protected]   
Browse latest Market Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs